ENERCA will be at the center of the debate with two devoted sessions at the 3rd Pan-European Conference

The 3rd Pan-European Conference on Haemoglobinopathies & Rare Anaemias is about to begin. ENERCA will be there, presenting the experience of 10 years of joint efforts

October 18th 2012

3rd Pan-European Conference on Haemoglobinopathies & Rare Anaemias

The Pan-European Conference is an international meeting oriented to all the key players in Haemoglobinopathies & Rare Anaemias, including patients and patient organisations, healthcare professionals, academics, researchers, policy-makers and industry. Organized by the (TIF), the Conference will bring together stakeholders from the 27 Member States of the European Union as well as from other states of the Council of Europe and countries of neighbouring regions. Together they will discuss avenues of action to tackle health inequalities across the EU and the growing public health burden of chronic and rare diseases, with a particular focus on patient rights as well as new and upcoming policies that are directly or indirectly related to health and quality of life.

On addition of being among the event organizers, ENERCA will be on the center of attention during two dedicated sessions on October 26th. The debate will focus on the role of Experts Centres, cross-border health, the improvement of education and training on rare anaemias, and laboratory diagnosis, epidemiology and screening issues. All this will be possible thanks to the sponsorship of SEBIA, a company selling innovative laboratory instruments and reagents based on electrophoresis technology, Novartis, a healthcare solutions provider for the evolving needs of patients and societies, and Vienna Lab, a company offering customized solutions for genetic testing.

Sebia and Vienna Lab sponsor ENERCA at the TIF 3rd Pan-European Conference

Copyright © 2002 - 2020 Enerca

Co-funded by the Health Programme of the European Union.